Transcriptional regulatory fusion polypeptide
US-2019330280-A1 · Oct 31, 2019 · US
US11414456B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11414456-B2 |
| Application number | US-201816771009-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 10, 2018 |
| Priority date | Dec 11, 2017 |
| Publication date | Aug 16, 2022 |
| Grant date | Aug 16, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application provides a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 1, a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 2 and a cell penetrating peptide consisting of the amino acid sequence of SEQ ID NO: 3; and a complex comprising any one of the cell penetrating peptide and a functional molecule.
Opening claim text (preview).
The invention claimed is: 1. A peptide consisting of the amino acid sequence of SEQ ID NO: 1.
having 5 to 11 amino acids · CPC title
containing a GST-tag · CPC title
containing a localisation/targetting motif · CPC title
containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.